Clinical Research Directory
Browse clinical research sites, groups, and studies.
Vestibular Innovation in Pain 2
Sponsor: Icahn School of Medicine at Mount Sinai
Summary
Fibromyalgia is the most common centralized pain disorder, affecting up to 3% of the population. Current treatments are incompletely effective, often poorly tolerated, and costly: there remains an urgent need for novel, effective, and well-tolerated therapy. Preliminary data suggests that vestibulocortical stimulation (VCS), or irrigating the external ear canal with temperate water, could rapidly improve pain and quality of life in this cohort. The VIPR trial will assess the efficacy of a single session of VCS - a safe \& cost-effective bedside technique using a plastic syringe and temperate water - relative to sham in treating pain \& improving quality of life using validated patient-reported outcomes.
Official title: Vestibular Innovation in Pain: A Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
56
Start Date
2026-02
Completion Date
2027-07-31
Last Updated
2026-02-20
Healthy Volunteers
No
Conditions
Interventions
Vestibulocortical Stimulation
VCS is a non-invasive bedside procedure using temperate water, and a plastic syringe (no needles). With the participant laying supine, temperate water is irrigated into the external ear canal at 1-2 cc/second.
Locations (1)
Mount Sinai West
New York, New York, United States